SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-133133
Filing Date
2024-05-07
Accepted
2024-05-07 16:18:06
Documents
15
Period of Report
2024-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d802970d8k.htm   iXBRL 8-K 24248
2 EX-99.1 d802970dex991.htm EX-99.1 143434
6 GRAPHIC g802970g0507090546918.jpg GRAPHIC 2975
  Complete submission text file 0001193125-24-133133.txt   312230

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA btmd-20240507.xsd EX-101.SCH 2841
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE btmd-20240507_lab.xml EX-101.LAB 17978
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE btmd-20240507_pre.xml EX-101.PRE 11252
18 EXTRACTED XBRL INSTANCE DOCUMENT d802970d8k_htm.xml XML 3634
Mailing Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038
Business Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038 972-486-9346
biote Corp. (Filer) CIK: 0001819253 (see all company filings)

IRS No.: 851791125 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40128 | Film No.: 24922188
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)